NewSquare Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
NewSquare Capital's NVO Position: Q3 2025 in Review
NewSquare Capital sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 444 shares — an estimated $30.6K sold.
NewSquare Capital first reported a position in NVO in Q3 2013 and held it in 19 quarters. The position peaked at $5.38M in Q2 2024. 1,400 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- NewSquare Capital reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- NewSquare Capital sold 444 Novo Nordisk shares in Q3 2025, an estimated $30.6K.
- NewSquare Capital first reported a position in Novo Nordisk in Q3 2013 and held it in 19 quarters.
- NewSquare Capital's Novo Nordisk position peaked at $5.38M in Q2 2024.
- 1,400 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.